Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study. Issue 3 (February 2018)
- Record Type:
- Journal Article
- Title:
- Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study. Issue 3 (February 2018)
- Main Title:
- Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study
- Authors:
- Imam, Syed Z
He, Zhen
Cuevas, Elvis
Rosas-Hernandez, Hector
Lantz, Susan M
Sarkar, Sumit
Raymick, James
Robinson, Bonnie
Hanig, Joseph P
Herr, David
MacMillan, Denise
Smith, Aaron
Liachenko, Serguei
Ferguson, Sherry
O'Callaghan, James
Miller, Diane
Somps, Christopher
Pardo, Ingrid D
Slikker Jr, William
B Pierson, Jennifer
Roberts, Ruth
Gong, Binsheng
Tong, Weida
Aschner, Michael
J Kallman, Mary
Calligaro, David
Paule, Merle G - Abstract:
- Neurotoxicity has been linked with exposure to a number of common drugs and chemicals, yet efficient, accurate, and minimally invasive methods to detect it are lacking. Fluid-based biomarkers such as those found in serum, plasma, urine, and cerebrospinal fluid have great potential due to the relative ease of sampling but at present, data on their expression and translation are lacking or inconsistent. In this pilot study using a trimethyl tin rat model of central nervous system toxicity, we have applied state-of-the-art assessment techniques to identify potential individual biomarkers and patterns of biomarkers in serum, plasma, urine or cerebral spinal fluid that may be indicative of nerve cell damage and degeneration. Overall changes in metabolites and microRNAs were observed in biological fluids that were associated with neurotoxic damage induced by trimethyl tin. Behavioral changes and magnetic resonance imaging T2 relaxation and ventricle volume changes served to identify animals that responded to the adverse effects of trimethyl tin. Impact statement: These data will help design follow-on studies with other known neurotoxicants to be used to assess the broad applicability of the present findings. Together this approach represents an effort to begin to develop and qualify a set of translational biochemical markers of neurotoxicity that will be readily accessible in humans. Such biomarkers could prove invaluable for drug development research ranging from preclinicalNeurotoxicity has been linked with exposure to a number of common drugs and chemicals, yet efficient, accurate, and minimally invasive methods to detect it are lacking. Fluid-based biomarkers such as those found in serum, plasma, urine, and cerebrospinal fluid have great potential due to the relative ease of sampling but at present, data on their expression and translation are lacking or inconsistent. In this pilot study using a trimethyl tin rat model of central nervous system toxicity, we have applied state-of-the-art assessment techniques to identify potential individual biomarkers and patterns of biomarkers in serum, plasma, urine or cerebral spinal fluid that may be indicative of nerve cell damage and degeneration. Overall changes in metabolites and microRNAs were observed in biological fluids that were associated with neurotoxic damage induced by trimethyl tin. Behavioral changes and magnetic resonance imaging T2 relaxation and ventricle volume changes served to identify animals that responded to the adverse effects of trimethyl tin. Impact statement: These data will help design follow-on studies with other known neurotoxicants to be used to assess the broad applicability of the present findings. Together this approach represents an effort to begin to develop and qualify a set of translational biochemical markers of neurotoxicity that will be readily accessible in humans. Such biomarkers could prove invaluable for drug development research ranging from preclinical studies to clinical trials and may prove to assist with monitoring of the severity and life cycle of brain lesions. … (more)
- Is Part Of:
- Experimental biology and medicine. Volume 243:Issue 3(2018)
- Journal:
- Experimental biology and medicine
- Issue:
- Volume 243:Issue 3(2018)
- Issue Display:
- Volume 243, Issue 3 (2018)
- Year:
- 2018
- Volume:
- 243
- Issue:
- 3
- Issue Sort Value:
- 2018-0243-0003-0000
- Page Start:
- 228
- Page End:
- 236
- Publication Date:
- 2018-02
- Subjects:
- Bioimaging -- biomarkers -- brain -- neurobiology -- neurotoxicology -- translational
Physiology -- Periodicals
Biology, Experimental -- Periodicals
Medicine, Experimental -- Periodicals
610.72 - Journal URLs:
- http://ebm.rsmjournals.com/ ↗
http://ebm.sagepub.com/ ↗
http://www.ebmonline.org ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/1535370217739859 ↗
- Languages:
- English
- ISSNs:
- 1535-3702
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8248.xml